Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
| Cat.No. | Product Name | Price |
|---|---|---|
| CSC-DC004030 | Panoply™ Human DARS Knockdown Stable Cell Line | Inquiry |
| CSC-SC004030 | Panoply™ Human DARS Over-expressing Stable Cell Line | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| AD04588Z | Human DARS adenoviral particles | Inquiry |
| LV10299L | human DARS (NM_001349) lentivirus particles | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| SHH274601 | shRNA set against Human DARS (NM_001349.2) | Inquiry |
| SHH274605 | shRNA set against Mouse DARS (NM_177445.5) | Inquiry |
| SHH274609 | shRNA set against Rat DARS (NM_053799.2) | Inquiry |
| SHW000608 | shRNA set against Chicken DARS (NM_001006528) | Inquiry |
| SHW010691 | shRNA set against Danio rerio DARS (NM_001077611) | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| CDCB162083 | Chicken DARS ORF Clone (NM_001006528) | Inquiry |
| CDFH004760 | Human DARS cDNA Clone(NM_001349.2) | Inquiry |
| CDFL003433 | Mouse Dars cDNA Clone(NM_145507.2) | Inquiry |
| CDFR013541 | Rat Dars cDNA Clone(NM_053799.2) | Inquiry |
| MiUTR1H-02670 | DARS miRNA 3'UTR clone | Inquiry |
| CDCB159225 | Human DARS ORF clone (BC000629) | Inquiry |
| CDCB172166 | Danio rerio DARS ORF Clone (NM_001077611) | Inquiry |
| CDCB191096 | Rabbit DARS ORF clone (XM_002712122.2) | Inquiry |
| CDCR053494 | Mouse Dars ORF clone (NM_145507.2) | Inquiry |
| CDCR273944 | Mouse Dars ORF Clone(NM_177445.5) | Inquiry |
| CDCR280588 | Human DARS ORF Clone(NM_001349.2) | Inquiry |
| CDCR380573 | Rat Dars ORF Clone(NM_053799.2) | Inquiry |
| CDCS410242 | Human DARS ORF Clone (BC000629) | Inquiry |
Aspartyl-tRNA synthetase (Dars) is a vital enzyme involved in protein synthesis, specifically in the process of tRNA aminoacylation. This enzyme belongs to the aminoacyl-tRNA synthetase family, responsible for catalyzing the attachment of specific amino acids to their corresponding tRNA molecules, a fundamental step in translation. Dars specifically charges tRNA molecules with aspartic acid, ensuring their accurate incorporation into nascent polypeptide chains during protein synthesis. By recognizing the unique structure of aspartic acid and the corresponding tRNA, Dars plays a critical role in maintaining the fidelity and efficiency of the translation process. Moreover, emerging research indicates that Dars might possess additional functions beyond its canonical role in translation, implicating it in various cellular processes and diseases.
Aspartyl-tRNA synthetase (Dars) is a key enzyme in the process of translation, ensuring the accurate incorporation of aspartic acid into growing polypeptide chains. As a member of the aminoacyl-tRNA synthetase family, Dars specifically charges its cognate tRNA molecules with aspartic acid, a crucial step for the fidelity of translation. During protein synthesis, Dars recognizes the unique structural features of aspartic acid and the corresponding tRNA, catalyzing their precise pairing. By meticulously facilitating this aminoacylation process, Dars plays a fundamental role in maintaining the integrity and functionality of cellular proteins. Its accuracy in ensuring the correct amino acid incorporation underscores its significance in the synthesis of functional proteins essential for various biological processes.
Aspartyl-tRNA synthetase (Dars), traditionally recognized for its involvement in protein synthesis, has recently emerged as a multifunctional enzyme with roles extending beyond translation. Studies indicate that Dars participates in cell signaling processes, potentially influencing various cellular pathways. One of its newfound functions involves modulating the mTOR (mechanistic Target of Rapamycin) signaling pathway, a crucial regulator of cell growth and metabolism. Dars interacts with components of the mTOR complex, suggesting its involvement in the intricate network of cellular signaling cascades. Moreover, recent research has linked Dars to stress response pathways, indicating its potential role in cellular adaptation to environmental challenges.
Aspartyl-tRNA synthetase (Dars) has gained attention in cancer research due to its emerging association with tumorigenesis and cancer progression. Studies have revealed altered expression levels and dysregulated activities of Dars in various cancer types. Dysfunctional Dars has been implicated in promoting cancer cell survival, proliferation, and invasion. It is also involved in regulating the translation of specific mRNA transcripts critical for cancer cell growth. Moreover, Dars interacts with components of cellular signaling pathways that play pivotal roles in cancer development.
Additionally, recent research has highlighted the potential of Dars as a therapeutic target. Modulating Dars activity or targeting its interactions in cancer cells holds promise for developing innovative anticancer strategies. Understanding the intricate relationship between Dars and cancer provides valuable insights into the molecular mechanisms underlying tumorigenesis, offering avenues for targeted therapies and personalized treatment approaches in the fight against cancer.
References: